Therapeutic Outcomes of High-Dose Intravenous Steroids in the Treatment of Dysthyroid Optic Neuropathy
Thyroid2014Vol. 24(5), pp. 897–905
Citations Over TimeTop 10% of 2014 papers
Nicola Currò, Danila Covelli, Guia Vannucchi, Irene Campi, Giacinta Pirola, Simona Simonetta, Davide Dazzi, Claudio Guastella, Lorenzo Pignataro, Paolo Beck‐Peccoz, Roberto Ratiglia, Mario Salvi
Abstract
High-dose iv-MP was effective in permanently restoring visual function in about 40% of the eyes treated. When successful, it generally induced inactivation of the orbital disease within two weeks and normalization of visual function within one month. The presence of optic disc swelling at diagnosis and persistent active disease at two weeks were good predictors of unresponsiveness to steroids.
Related Papers
- → Quantitative Morphologic and Functional Evaluation of the Optic Nerve Head in Chronic Open-Angle Glaucoma(1999)66 cited
- Non-arteritic anterior ischaemic optic neuropathy (NA-AION): outcome for visual acuity and visual field defects, the Singapore scene 2.(2012)
- → Tobacco-Alcohol Toxic Optic Neuropathy(2019)4 cited
- → Correlation of optic disc morphology and ocular perfusion parameters in patients with primary open angle glaucoma(2008)8 cited
- → Spontaneous Visual Improvement in Orbital Apex Tumors(1996)20 cited